These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

399 related items for PubMed ID: 3053901

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Enhancement of release of granulocyte- and granulocyte-macrophage colony-stimulating factors from phytohemagglutinin-stimulated sorted subsets of human T lymphocytes by recombinant human tumor necrosis factor-alpha. Synergism with recombinant human IFN-gamma.
    Lu L, Srour EF, Warren DJ, Walker D, Graham CD, Walker EB, Jansen J, Broxmeyer HE.
    J Immunol; 1988 Jul 01; 141(1):201-7. PubMed ID: 2454257
    [Abstract] [Full Text] [Related]

  • 26. Macrophage growth factor CSF-1 stimulates human monocyte production of interferon, tumor necrosis factor, and colony stimulating activity.
    Warren MK, Ralph P.
    J Immunol; 1986 Oct 01; 137(7):2281-5. PubMed ID: 2428865
    [Abstract] [Full Text] [Related]

  • 27. Effect of human recombinant granulocyte-macrophage colony-stimulating factor and IL-3 on the expression of surface markers of human monocyte-derived macrophages in long-term cultures.
    Dimri R, Nissimov L, Keisari Y.
    Lymphokine Cytokine Res; 1994 Aug 01; 13(4):239-45. PubMed ID: 7528061
    [Abstract] [Full Text] [Related]

  • 28. Activities of granulocyte-macrophage colony-stimulating factor and interleukin-3 on monocytes.
    Suzuki H, Katayama N, Ikuta Y, Mukai K, Fujieda A, Mitani H, Araki H, Miyashita H, Hoshino N, Nishikawa H, Nishii K, Minami N, Shiku H.
    Am J Hematol; 2004 Apr 01; 75(4):179-89. PubMed ID: 15054806
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Recombinant interferons or interleukin-2 increase cytotoxicity by human monocytes and NK cells.
    Frey JR, Kamber M, Peck R.
    Lymphokine Res; 1987 Apr 01; 6(3):215-27. PubMed ID: 3114569
    [Abstract] [Full Text] [Related]

  • 31. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
    Tso CL, Zisman A, Pantuck A, Calilliw R, Hernandez JM, Paik S, Nguyen D, Gitlitz B, Shintaku PI, de Kernion J, Figlin R, Belldegrun A.
    Cancer Res; 2001 Nov 01; 61(21):7925-33. PubMed ID: 11691814
    [Abstract] [Full Text] [Related]

  • 32. Regulation by interleukin-3 of human monocyte pro-inflammatory mediators. Similarities with granulocyte-macrophage colony-stimulating factor.
    Hart PH, Whitty GA, Burgess DR, Hamilton JA.
    Immunology; 1990 Sep 01; 71(1):76-82. PubMed ID: 2120130
    [Abstract] [Full Text] [Related]

  • 33. Effects of recombinant human colony stimulating factors (CSF) (granulocyte-macrophage CSF, granulocyte CSF, and CSF-1) on human monocyte/macrophage differentiation.
    Geissler K, Harrington M, Srivastava C, Leemhuis T, Tricot G, Broxmeyer HE.
    J Immunol; 1989 Jul 01; 143(1):140-6. PubMed ID: 2471733
    [Abstract] [Full Text] [Related]

  • 34. Tumor necrosis factor and IL-1 associated with plasma membranes of activated human monocytes lyse monokine-sensitive but not monokine-resistant tumor cells whereas viable activated monocytes lyse both.
    Ichinose Y, Bakouche O, Tsao JY, Fidler IJ.
    J Immunol; 1988 Jul 15; 141(2):512-8. PubMed ID: 3260254
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. ONO-4007, an antitumor lipid A analog, induces tumor necrosis factor-alpha production by human monocytes only under primed state: different effects of ONO-4007 and lipopolysaccharide on cytokine production.
    Matsumoto N, Aze Y, Akimoto A, Fujita T.
    J Pharmacol Exp Ther; 1998 Jan 15; 284(1):189-95. PubMed ID: 9435177
    [Abstract] [Full Text] [Related]

  • 37. In vitro prevention and reversal of lipopolysaccharide desensitization by IFN-gamma, IL-12, and granulocyte-macrophage colony-stimulating factor.
    Randow F, Döcke WD, Bundschuh DS, Hartung T, Wendel A, Volk HD.
    J Immunol; 1997 Mar 15; 158(6):2911-8. PubMed ID: 9058829
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Cytolysis of tumor necrosis factor (TNF)-resistant tumor targets. Differential cytotoxicity of monocytes activated by the interferons, IL-2, and TNF.
    Philip R.
    J Immunol; 1988 Feb 15; 140(4):1345-9. PubMed ID: 2449501
    [Abstract] [Full Text] [Related]

  • 40. A novel differentiation antigen on human monocytes that is specifically induced by granulocyte-macrophage colony-stimulating factor or IL-3.
    Maeda K, Sone S, Ohmoto Y, Ogura T.
    J Immunol; 1991 Jun 01; 146(11):3779-84. PubMed ID: 1903413
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.